Lavendustin C is a potent inhibitor of Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) (IC₅₀ = 0.2 µM), EGFR-associated tyrosine kinase (IC₅₀ = 0.012 µM), and pp60c-src(+) kinase (IC₅₀ = 0.5 µM); it inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation (at 10–150 µM) and may serve as the core structure responsible for tyrosine kinase inhibition.